HN 01-01IMMUNOLOGY OF HPV DRIVEN OROPHARYNGEAL CANCER

27. HPV and oropharynx / Head and neck cancer
S.H. Van Der Burg 1, R. Goedemans 1, P. Charoentong 2, S. Santegoets 1, E. Jordanova 1, I. Ehsan 1, V. Van Ham 1, V. Van Unen 1, F. Koning 1, Z. Trajanoski 2, L.A. Van Der Velden 1, M.J. Welters 1.
1Leiden University Medical Center (Netherlands), 2Innsbruck Medical University (Austria)

Background / Objectives

Human papilloma virus (HPV)-associated oropharyngeal squamous cell cancer (OPSCC) is a distinct clinical entity with a much better prognosis after (chemo)radiotherapy than HPV-negative OPSCC. We hypothesize that the virally-derived E6 and E7 antigens make HPV-associated OPSCC highly visible to the immune system, unleashing a strong antitumor response. To understand the constitution of an optimal antitumor response we have unraveled the immune contexture of OPSCC.


Methods

A comprehensive analysis by mass cytometry (CyTOF), flow cytometry and immunohistochemistry was performed on fresh and archived tissue of a cohort of 97 patients.  In addition, the RNA-sequencing data of a cohort of 75 HPV16+ OPSCC patients present in the publicly available cancer genomic atlas (TCGA) database was used to analyze the tumor microenvironment by an analytical strategy to estimate subpopulations of tumor-infiltrating immune cells.


Results

CD4+ T cells formed the major component in OPSCC. Gene set enrichment analysis (GSEA) of the TCGA data in HPV16+ OPSCC with a high vs low CD4 gene expression revealed the enrichment of activated and effector memory CD4+ and CD8+ T cells as well as activated DC in HPV16+ OPSCC with a high expression of CD4. Indeed, flow- and mass-cytometry confirmed  an increased percentage of DCs and highly activated effector memory CD4+ and CD8+ T cells in HPV16+ OPSCC. Furthermore, immunohistochemistry showed that these T cells were likely to produce interferon-gamma. Interestingly, the T-cell infiltrate of HPV16+ OPSCC comprised a population of cells expressing a specific C-type lectin receptor. The expression of this receptor strongly correlated to the overall survival of patients with HPV16+ OPSCC and was expressed on type 1 T cells recognizing the HPV oncoproteins E6 and E7.


Conclusion

OPSCC are infiltrated with HPV-specific T cells expressing a C-type lectin receptor that is also expressed by CD4+ T-cells dominating inflammatory diseases such as rejections during graft versus host disease, hence a similar role may be expected in cancer and would be advantageous for tumor control.


References